Eren Erdal, Abuhandan Mahmut, Solmaz Abdullah, Taşkın Abdullah
Uludağ University, Faculty of Medicine, Department of Pediatric Endocrinology, Bursa, Turkey. E-ma-il:
J Clin Res Pediatr Endocrinol. 2014 Sep;6(3):163-8. doi: 10.4274/Jcrpe.1454.
This study aimed to measure paraoxonase/arylesterase activities and to evaluate the total oxidant and antioxidant capacities in obese children and in children with metabolic syndrome (MetS).
A total of 151 children of comparable ages (13.23±1.96 years, 13.45±1.85 years and 13.95±1.31 years) were enrolled in the study. Forty of these were children with MetS, 55 were obese and 56 were healthy controls. Diagnosis of the MetS was made according to International Diabetes Federation criteria. Paraoxonase/arylesterase activities were evaluated by using paraoxon and phenylacetate substrates. Total oxidant status (TOS) and total antioxidant status (TAS) were measured and oxidative stress index (OSI) was estimated by calculation.
High levels of paraoxonase were detected in the obese group, whereas high levels of arylesterase were detected in both MetS and obese groups. Higher values for TOS, TAS and OSI were found in the MetS group (p<0.05).
Higher values of mean TOS and OSI in the MetS group than those in the control groups indicate that these parameters may be indicators of future risks such as atherosclerosis in patients with MetS.
本研究旨在测定肥胖儿童及代谢综合征(MetS)患儿的对氧磷酶/芳基酯酶活性,并评估其总氧化能力和抗氧化能力。
共纳入151名年龄相仿的儿童(分别为13.23±1.96岁、13.45±1.85岁和13.95±1.31岁)。其中40名是患有MetS的儿童,55名肥胖儿童,56名是健康对照。根据国际糖尿病联盟标准对MetS进行诊断。使用对氧磷和苯乙酸底物评估对氧磷酶/芳基酯酶活性。测定总氧化状态(TOS)和总抗氧化状态(TAS),并通过计算估算氧化应激指数(OSI)。
肥胖组检测到高水平的对氧磷酶,而MetS组和肥胖组均检测到高水平的芳基酯酶。MetS组的TOS、TAS和OSI值更高(p<0.05)。
MetS组的平均TOS和OSI值高于对照组,表明这些参数可能是MetS患者未来发生动脉粥样硬化等风险的指标。